SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
艾欧
Lv4
440 积分
2022-05-05 加入
最近求助
最近应助
互助留言
Pharmacokinetics and pharmacodynamics of mibavademab (a leptin receptor agonist): Results from a first‐in‐human phase I study
25天前
已完结
GPR75: An exciting new target in metabolic syndrome and related disorders
1个月前
已完结
Glucagon-like peptide 1 and fibroblast growth factor-21 in non-alcoholic steatohepatitis: An experimental to clinical perspective
1个月前
已完结
Efruxifermin combined with a GLP-1 receptor agonist reduces liver fat in NASH
1个月前
已完结
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
1个月前
已完结
Tirzepatide Once Weekly for the Treatment of Obesity
3个月前
已完结
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity
5个月前
已完结
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity
5个月前
已完结
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity
5个月前
已完结
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension
5个月前
已完结
没有进行任何应助
无人应【积分已退回】
9个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论